Galectin-9

Galectin-9

Galectin-9 Overview

Molecule Name
Galactoside-binding lectin Galectin 9
Synonyms
Galectin-9,LGALS9,Ecalectin
Drug Development Progress
Drugs in Clinical Trials2
Approved Drugs0
Highest Development StagePhase 2 Clinical
Target Synonym
Ecalectin,Tumor antigen HOM-HD-21,Galectin-9,Lectin, Galactoside-Binding, Soluble, 9,LGALS9
Background
Galectin-9 (LGALS9) is also known as tumor antigen HOM-HD-21 and ecalectin. Galectins are a family of proteins defined by their binding specificity for β-galactoside sugars, such as N-acetyllactosamine (Galβ1-3GlcNAc or Galβ1-4GlcNAc), which can be bound to proteins by either N-linked or O-linked glycosylation. As for Galectin-9, it has high affinity for the Forssman pentasaccharide, and it is also the ligand for HAVCR2/TIM3. Forthermore, Galectin-9 stimulates bactericidal activity in infected macrophages by causing macrophage activation and IL1B secretion which restricts intracellular bacterial growth.

Galectin-9 Product List

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
LYT-200LYT-200Phase 2 ClinicalPuretech Health
Carcinoma, Transitional Cell; Cholangiocarcinoma; Colorectal Neoplasms; Head and Neck Neoplasms; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasm Metastasis; Pancreatic Neoplasms; Solid tumours
Details
Anti-Gal9 antibody (Fibrogen)FG-3165; HFB-200901; HFB-200902; HFB2009; HFB2009 series; HFB9-2Phase 1 ClinicalHiFiBiO Therapeutics
Solid tumours
Details